Aurinia Pharmaceuticals
AUPH
AUPH
143 hedge funds and large institutions have $803M invested in Aurinia Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 42 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
5.54% less ownership
Funds ownership: 51.4% → 45.86% (-5.5%)
15% less capital invested
Capital invested by funds: $946M → $803M (-$143M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
143
Holding in Top 10
2
Calls
$43.2M
Puts
$44.9M
Top Buyers
| 1 | +$12.2M | |
| 2 | +$9.51M | |
| 3 | +$9.31M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$5.23M |
| 5 |
FAM
Fred Alger Management
New York
|
+$4.9M |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$27.7M | |
| 3 | -$26.8M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$21.6M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$14.7M |